Hyperbaric oxygen (HBO) therapy has been used in our department since 1972, mainly to treat patients with sudden deafness [1], sensorineural loss of hearing, and Bell's palsy. Barotrauma, especially to the middle ear, is one of the most common complications of HBO treatment. The effect can be transient or long-lasting. Data from noncontrolled studies indicate that the incidence of middle ear barotrauma ranges from 5 to 82% [2][3][4][5].In the present retrospective study, we evaluated the incidence of middle ear complications in patients who had received HBO therapy in our institution. We also evaluated the relationship between the volume of the mastoid area of pneumatization and the incidence of middle ear barotrauma.
Materials and MethodsBetween 1972 and 1992, 898 patients received HBO therapy at the hospital of Nagoya University for conditions such as sudden deafness (SD), idiopathic bilateral sensorineural hearing loss (IBSHL), Bell's palsy, following the microtia procedure, or other diseases (table 1). Their ages ranged from 9 to 72 years (mean: 37). Of these patients, ears with perforated tympanic membrane (TM) or which lacked an external ear canal were excluded from study, leaving 1,737 ears for data analysis.To eliminate the risk of explosion and ensure safe treatment, HBO therapy was administered in a large air-filled chamber that can accommodate 10 people simultaneously. Every patient in the chamber inhaled pure oxygen from each face mask through treatment. HBO therapy was administered at a pressure of 2 atmosphere absolute (ATA) for 60 min. Compression to 2 ATA occurred in 7 min, whereas decompression required 13 min ( fig. 1). The TM was evaluated prior to each treatment. The Eustachian tube was inflated via a catheter